Why Read Pharmaceutical Approvals Monthly?
Pharmaceutical Approvals Monthly provides in-depth analysis of the U.S. drug development and approval process, including behind-the-scenes coverage of key FDA approval decisions. This specialized monthly publication also tracks pending applications at FDA, including user fee goals; FDA approvals and “complete response” actions; FDA advisory committee recommendations; and more, all with expert, in-depth analysis of these developments and their impact on your company.
Who Reads Pharmaceutical Approvals Monthly?
Biopharmaceutical C-suite executives, financial and investment analysts, marketing directors and legal advisors rely on Pharmaceutical Approvals Monthly to provide a comprehensive summary of the entire body of FDA action in one single, easy-to-use resource.
Subscription Terms
Subscription Options
Buy Now
Includes:
Email newsletter with latest headlines, breaking news alerts, and access to Pharmaceutical Approvals Monthly — in-depth coverage of U.S. drug approvals, including FDA approval actions by classification.
Multiple users/site features: Contact Deanna Flanick at +1-908-547-2141 or D.Flanick@Elsevier.com.